FindTrial
Sign In

The diagnostic value of FDG PET/CT in detection of bone malignancies: a singe-centre, retrospective, observational research

The diagnostic value of FDG PET/CT in detection of bone malignancies: a singe-centre, retrospective, observational research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018446
Enrollment
Unknown
Registered
2018-09-19
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone malignancies

Interventions

Gold Standard:Pathological examination
Index test:FDG PET/CT

Sponsors

The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.a FDG PET/CT scan out of malignancy and with at least one suspicious bone lesion; 2.a histopathological confirmation of the bone lesion; 3.the time interval between the FDG PET/CT and the histopathological confirmation within 1 month

Exclusion criteria

Exclusion criteria: 1.any anti-tumor therapy between PET/CT and histopathological confirmation; 2.the repeated PET/CT scans by the same patient.

Design outcomes

Primary

MeasureTime frame
malignancy rate;consistency rate;—

Countries

China

Contacts

Public ContactHui Zhao

The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University

ivy25502@hotmail.com+86 18758855975

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026